Universe Pharmaceuticals (UPC) Change in Accured Expenses: 2021-2024
- Universe Pharmaceuticals' Change in Accured Expenses fell 4.47% to -$2.7 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$112,020, marking a year-over-year decrease of 19.06%. This contributed to the annual value of -$1.2 million for FY2024, which is 578.33% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Change in Accured Expenses stood at -$2.7 million for Q1 2024, which was down 201.05% from $2.7 million recorded in Q3 2023.
- Over the past 5 years, Universe Pharmaceuticals' Change in Accured Expenses peaked at $2.7 million during Q3 2023, and registered a low of -$2.7 million during Q1 2024.
- In the last 3 years, Universe Pharmaceuticals' Change in Accured Expenses had a median value of -$454,847 in 2022 and averaged -$113,373.
- In the last 5 years, Universe Pharmaceuticals' Change in Accured Expenses spiked by 471.52% in 2022 and then crashed by 476.66% in 2023.
- Quarterly analysis of 4 years shows Universe Pharmaceuticals' Change in Accured Expenses stood at $444,319 in 2021, then skyrocketed by 471.52% to $2.5 million in 2022, then rose by 6.79% to $2.7 million in 2023, then declined by 4.47% to -$2.7 million in 2024.
- Its last three reported values are -$2.7 million in Q1 2024, $2.7 million for Q3 2023, and -$2.6 million during Q1 2023.
